Effect of ureteral stent diameter on ureteral stent-related symptoms.
stent diameter
ureteral stent
urinary symptoms
Journal
Lower urinary tract symptoms
ISSN: 1757-5672
Titre abrégé: Low Urin Tract Symptoms
Pays: Australia
ID NLM: 101506777
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
26
10
2018
revised:
07
01
2019
accepted:
19
02
2019
pubmed:
9
4
2019
medline:
13
2
2020
entrez:
9
4
2019
Statut:
ppublish
Résumé
This study investigated the correlation between ureteral stent diameter and stent-related symptoms. This study evaluated 17 patients (53 [74.6%] men, 18 [25.4%] women; mean [±SD] age 59.3 ± 14.2 years) who underwent ureteral stent placement before ureteroscopic lithotripsy (URSL) and in whom the ureteral stent tail was positioned inside the bladder without crossing the midline. All stents were Inlay Optima stents. Stent diameter (6 or 4.7 Fr) and length (24 or 26 cm) were chosen at the surgeon's discretion. Patients were classified into two groups (Group 1, 6-Fr stent; Group 2, 4.7-Fr stent). Urinary symptoms before insertion of the ureteral stents and the day before URSL were assessed using the International Prostate Symptom Score (IPSS) and Overactive Bladder Symptom Score (OABSS). In addition, patient background and changes in the IPSS and OABSS were compared. Factors affecting ureteral stent-related symptoms were evaluated using multivariate analysis. Compared with Group 2, Group 1 had a worse total IPSS (P = 0.02), as well as intermittency (P = 0.009), urgency (P = 0.008), voiding symptoms (Q1 + Q3 + Q5 + Q6; P = 0.046), and storage symptoms (Q2 + Q4 + Q7; P = 0.017) subscores on the IPSS, total OABSS (P = 0.045) and OABSS urgency subscore (P = 0.002). Multivariate analysis revealed that stent diameter was significantly associated with total IPSS (P = 0.007) and OABSS (P = 0.036). This is the first study to show that larger-diameter ureteral stents induce significantly worse urinary symptoms. Ureteral stents with smaller diameters are recommended to improve ureteral stent-related symptoms.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
195-199Informations de copyright
© 2019 John Wiley & Sons Australia, Ltd.
Références
Zimskind PD, Fetter TR, Wilkerson JL. Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol. 1967;97:840-844.
Joshi HB, Okeke A, Newns N, Keeley FX Jr, Timoney AG. Characterization of urinary symptoms in patients with ureteral stents. Urology. 2002;59:511-519.
Rane A, Saleemi A, Cahill D, Sriprasad S, Shrotri N, Tiptaft R. Have stent related symptoms anything to do with placement technique? J Endourol. 2001;15:741-745.
Al-Kandari AM, Al-Shaiji TF, Shaaban H, et al. Effects of proximal and distal ends of double-J ureteral stent position on postprocedural symptoms and quality of life: a randomized clinical trial. J Endourol. 2007;21:698-702.
Damiano R, Autorino R, De Sio M, et al. Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study. Eur Urol. 2005;48:673-678.
Erturk E, Sessions A, Joseph JV. Impact of ureteral stent diameter on symptoms and tolerability. J Endourol. 2003;17:59-62.
Candela JV, Bellman GC. Ureteral stents: impact of diameter and composition on patient symptoms. J Endourol. 1997;11:45-47.
Pollard SG, Macfarlane R. Symptoms arising from double-J ureteral stents. J Urol. 1988;139:37-38.
Chandhoke PS, Barqawi AZ, Wernecke C, et al. A randomized outcomes trial of ureteral stents for extracorporeal shock wave lithotripsy of solitary kidney or proximal ureteral stones. J Urol. 2002;167:1981-1983.
Sighinolfi MC, Micali S, De Stefani S, et al. Indwelling ureteral stents and sexual health: a prospective, multivariate analysis. J Urol. 2007;178:229-231.
Lennon GM, Thornhill JA, Sweeney PA, Grainger R, McDermott TED, Butler MR. “Firm” versus “soft” double pigtail ureteric stents: a randomised blind comparative trial. Eur Urol. 1995;28:1-5.
Giannarini G, Keeley FX Jr, Valent F, et al. Predictors of morbidity in patients with indwelling ureteric stents: results of a prospective study using the validated Ureteric Stent Symptoms Questionnaire. BJU Int. 2010;107:648-654.
Taguchi M, Yoshida K, Sugi M, Matsuda T, Kinoshita H. A ureteral stent crossing the bladder midline leads to worse urinary symptoms. Cent European J Urol. 2017;70:412-417.
Lingeman JE, Preminger GM, Goldfischer ER, Krambeck AE, The Comfort Study Team. Assessing the impact of ureteral stent design on patient comfort. J Urol. 2009;181:2581-2587.
Taguchi M, Inoue T, Muguruma K, Murota T, Kinoshita H, Matsuda T. Impact of loop-tail ureteral stents on ureteral stent-related symptoms immediately after ureteroscopic lithotripsy: comparison with pigtail ureteral stents. Investig Clin Urol. 2017;58:440-446.
Leibovici D, Cooper A, Lindner A, et al. Ureteral stents: morbidity and impact on quality of life. Isr Med Assoc J. 2005;7:491-494.
Assimos D, Crisci A, Culkin D, et al. Preoperative JJ stents placement in ureteric and renal stone treatment: results from the Clinical Research Office of Endourological Society (CROES) ureteroscopy (URS) Global Study. BJU Int. 2015;117:648-654.
Joshi HB, Newns N, Stainthorpe A, et al. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol. 2003;169:1060-1064.
Joshi HB, Stainthorpe A, Keeley FX Jr, et al. Indwelling ureteral stents: evaluation of quality of life to aid outcome analysis. J Endourol. 2001;15:151-154.
Miyaoka R, Monga M. Ureteral stent discomfort: etiology and management. Indian J Urol. 2009;25:455-460.
Homma Y, Yoshida M, Seki N, et al. Symptom assessment tool for overactive bladder syndrome - overactive bladder symptom score. Urology. 2006;68:318-323.
Homma Y, Gotoh M. Symptom severity and patient perceptions in overactive bladder: how are they related? BJU Int. 2009;104:968-972.
Irani J, Siquier J, Pirès C, Lefebvre O, Doré B, Aubert J. Symptom characteristics and the development of tolerance with time in patients with indwelling double-pigtail ureteric stents. BJU Int. 1999;84:276-279.
Kuehhas FE, Miernik A, Sharma V, et al. A prospective evaluation of pain associated with stone passage, stents, and stent removal using a visual analog scale. Urology. 2013;82:521-525.
Chew BH, Rebullar KA, Harriman D, McDougall E, Paterson RF, Lange D. Percuflex helical ureteral stents significantly reduce patient analgesic requirements compared to control stents. J Endourol. 2017;31:1321-1325.
Park HK, Paick SH, Kim HG, Lho YS, Bae S. The impact of ureteral stent type on patient symptoms as determined by the ureteral stent symptom questionnaire: a prospective, randomized, controlled study. J Endourol. 2015;29:367-371.
Lee JN, Kim BS. Comparison of efficacy and bladder irritation symptoms among three different ureteral stents: a double-blind, prospective, randomized controlled trial. Scand J Urol. 2015;49:237-241.